These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 25265255

  • 1. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
    Shuker N, Cadogan M, van Gelder T, Roodnat JI, Kho MM, Weimar W, Hesselink DA.
    Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen.
    Meçule A, Tinti F, Bachetoni A, Poli L, D'Alessandro M, Alessandri C, Umbro I, Nofroni I, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2011 May; 43(4):1017-9. PubMed ID: 21620040
    [Abstract] [Full Text] [Related]

  • 3. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A, Tredger JM, Heneghan M, Agarwal K, Samyn M, Heaton ND, O'Grady JG, Aluvihare VR.
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [Abstract] [Full Text] [Related]

  • 4. Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients.
    Kannegieter NM, Shuker N, Vafadari R, Weimar W, Hesselink DA, Baan CC.
    Ther Drug Monit; 2016 Apr; 38(2):280-4. PubMed ID: 26606072
    [Abstract] [Full Text] [Related]

  • 5. Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation.
    de Jonge H, Kuypers DR, Verbeke K, Vanrenterghem Y.
    Transplantation; 2010 Sep 15; 90(5):523-9. PubMed ID: 20592652
    [Abstract] [Full Text] [Related]

  • 6. Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.
    Uchida J, Kuwabara N, Machida Y, Iwai T, Naganuma T, Kumada N, Nakatani T.
    Transplant Proc; 2012 Jan 15; 44(1):128-33. PubMed ID: 22310596
    [Abstract] [Full Text] [Related]

  • 7. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.
    Transplant Proc; 2012 Jan 15; 44(1):121-3. PubMed ID: 22310594
    [Abstract] [Full Text] [Related]

  • 8. Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.
    Giannelli V, Rossi M, Giusto M, Lucidi C, Lattanzi B, Ruffa A, Ginanni Corradini S, Mennini G, Melandro F, Lai Q, Berloco P, Merli M.
    Eur Rev Med Pharmacol Sci; 2013 Oct 15; 17(20):2718-20. PubMed ID: 24174352
    [Abstract] [Full Text] [Related]

  • 9. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.
    Pharmacol Res; 2018 Mar 15; 129():84-94. PubMed ID: 29229354
    [Abstract] [Full Text] [Related]

  • 10. Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study.
    Sukkha S, Suansanae T, Iamrahong P, Wiwattanathum P.
    Transplant Proc; 2020 Apr 15; 52(3):775-779. PubMed ID: 32143870
    [Abstract] [Full Text] [Related]

  • 11. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH, Lee SD, Kim YK, Park SJ.
    Hepatobiliary Pancreat Dis Int; 2015 Aug 15; 14(4):374-9. PubMed ID: 26256081
    [Abstract] [Full Text] [Related]

  • 12. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
    Kolonko A, Chudek J, Wiecek A.
    Transplant Proc; 2011 Oct 15; 43(8):2950-3. PubMed ID: 21996198
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.
    Slatinska J, Rohal T, Wohlfahrtova M, Viklicky O.
    Transplant Proc; 2013 May 15; 45(4):1491-6. PubMed ID: 23726604
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A, Tinti F, Poli L, Bachetoni A, Umbro I, Nofroni I, Lai Q, Pretagostini R, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2011 May 15; 43(4):1024-7. PubMed ID: 21620042
    [Abstract] [Full Text] [Related]

  • 15. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
    Niioka T, Satoh S, Kagaya H, Numakura K, Inoue T, Saito M, Narita S, Tsuchiya N, Habuchi T, Miura M.
    Transplantation; 2012 Nov 27; 94(10):1013-9. PubMed ID: 23073468
    [Abstract] [Full Text] [Related]

  • 16. Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation.
    Stifft F, Stolk LM, Undre N, van Hooff JP, Christiaans MH.
    Transplantation; 2014 Apr 15; 97(7):775-80. PubMed ID: 24686426
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y, Hama K, Katayama H, Soga A, Toraishi T, Yokoyama T, Kihara Y, Jojima Y, Konno O, Iwamoto H, Takeuchi H, Hirano T, Shimazu M.
    Transplant Proc; 2012 Jan 15; 44(1):124-7. PubMed ID: 22310595
    [Abstract] [Full Text] [Related]

  • 18. Long-term Glomerular Filtration Rate and Kidney Disease: Improving Global Outcomes Stage Stability After Conversion to Once-Daily Tacrolimus in Kidney Transplant Recipients.
    Tinti F, Umbro I, Poli L, Cappoli A, Garofalo M, Bachetoni A, D'Alessandro MD, Lai S, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2019 Jan 15; 51(1):147-152. PubMed ID: 30655133
    [Abstract] [Full Text] [Related]

  • 19. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J, del Castillo D, Cabello M, Pallardó L, Grinyó JM, Fernández AM, Brunet M.
    Transplantation; 2010 Apr 27; 89(8):994-1000. PubMed ID: 20335831
    [Abstract] [Full Text] [Related]

  • 20. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J, Guillaud O, Boillot O.
    Liver Transpl; 2013 May 27; 19(5):529-33. PubMed ID: 23483701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.